Cargando…
In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by mutations in the dystrophin gene. To enable the non-invasive analysis of DMD gene correction strategies in vivo, we introduced a luciferase reporter in-frame with the C-terminus of the dystrophin gene in mice. Expression of this...
Autores principales: | Amoasii, Leonela, Li, Hui, Zhang, Yu, Min, Yi-Li, Sanchez-Ortiz, Efrain, Shelton, John M., Long, Chengzu, Mireault, Alex A., Bhattacharyya, Samadrita, McAnally, John R., Bassel-Duby, Rhonda, Olson, Eric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778191/ https://www.ncbi.nlm.nih.gov/pubmed/31586095 http://dx.doi.org/10.1038/s41467-019-12335-x |
Ejemplares similares
-
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
por: Min, Yi-Li, et al.
Publicado: (2019) -
CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice
por: Zhang, Yu, et al.
Publicado: (2017) -
A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing
por: Zhang, Yu, et al.
Publicado: (2022) -
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
por: Zhang, Yu, et al.
Publicado: (2020) -
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
por: Zhang, Yu, et al.
Publicado: (2021)